Namyang Dairy is in trouble after a number of furious investors have called for a boycott. They urged the consumers to stop buying the company’s products.
Namyang’s COVID-19 claim
The root cause of this action from the investors was Namyang Dairy’s claim that its Bulgaris yogurt drink can help fight the symptoms of COVID-19. Last week, the South Korean food and dairy company said that its stock price increased by more than eight percent on April 13 and continued to go up to over 28% the next day.
At that time, it was reported that Namyang’s share surge was caused by the consumers’ rush to buy its Bulgaris yogurt after it released a statement saying that the product can prevent COVID-19. However, health officials are questioning the company’s claims and suggested that they are false and have no scientific basis.
The controversial claim was announced during a symposium hosted by the Korea Research & Institute of BioMedical last week. At the event, Namyang’s internal research institute presented the results of its research on Yogurt drink called Bulgaris, as per The Korea Herald.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Company’s representative, Park Jong Su, said at the symposium. “Our experiments showed that Bulgaris helped remove the influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
S. Korea’s food and drug ministry reacts
The experts from the Ministry of Food and Drug Safety and Korea Disease Control and Prevention Agency immediately questioned Namyang’s statements about its Bulgaris yogurt. They are asking about the effectiveness claim against COVID-19 and they concluded that the dairy firm exaggerated the research results that it released in the previous symposium.
The Korea Times reported that because of this, the investors are now taking action against Namyang. They are using social media to ask the public to join in their calls to boycott the company’s products. Apparently, they are angry not just due to the coronavirus statements but also because they believe Namyang lied to manipulate the stock price.
Meanwhile, amid the backlash from the public and health experts, Namyang Dairy issued an apology for the confusion. "We apologize to our customers for causing misunderstanding with our research results,” a company official stated. “The test was not based on human testing, but at the cellular stage, from which we couldn't have concluded its effectiveness against COVID-19."


OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income
Coinbase Q1 2026 Earnings Miss Sends COIN Stock Lower Amid Crypto Market Slump
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal
Dollar Struggles to Rally Despite Strong US Data as Fed Hike Expectations Remain Limited
Trump to Visit China for Key U.S.-China Summit With Xi Jinping
Reliance Industries Reworks Jio IPO Into Fresh Share Sale Amid Valuation Talks
Saudi Aramco Q1 Profit Jumps 25% as Strait of Hormuz Crisis Reshapes Oil Exports
Indian Stock Market Drops as Iran Conflict Fuels Oil Price and Inflation Fears
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat
KOSPI Hits Record High as AI Chip Demand Boosts Samsung and SK Hynix
Australia Budget 2026: Smaller Deficit Expected Amid Tax Reform Push
Morgan Stanley Bets on Optical Component Stocks in Greater China Tech Sector
Wall Street Hits Record High as AI Chip Stocks and Strong U.S. Jobs Data Boost Markets
AcadeMedia Q3 Profit Climbs as International and Adult Education Segments Drive Growth
South Korea Central Bank Signals Inflation Concerns as Oil Prices Surge
JD Sports Backs Nike CEO Elliott Hill Amid Brand Turnaround Efforts
Dollar Slips as Strong U.S. Jobs Data Reduces Fed Rate Cut Expectations 



